Shares of pharmaceutical companies declined after U.S. President Donald Trump announced plans to lower U.S. prescription drug prices to match those in other countries. In a post on Truth Social, Trump said that he would sign an executive order to reduce drug prices by 30% to 80%. Shares of Eli Lilly (NYSE:LLY) shed 2.2%, Amgen (NASDAQ:AMGN) -2.6%, …